Ilias Biologics Inc.
ILIAS Biologics Inc. (previously Cellex Life Sciences, Inc.) was established in 2015 in South Korea to develop exosome-based therapeutics. ILIAS is currently developing various pipelines including inflammatory diseases and oncology.
Last updated on
About Ilias Biologics Inc.
Founded
2015Employees
11-50Funding / Mkt. Cap
$38MCategory
Industry
BiotechnologyLocation
City
DaejeonState
New YorkCountry
United StatesTech Stack (9)
